Beijing Geek Gene Technology

Beijing Geek Gene Technology Co., Ltd. is an innovative cell therapy company that leverages high-throughput omics data to guide cell fate for drug development. The company's primary focus is on producing high-quality T-cells for treating mid to late-stage solid tumors.

The company was founded in 2016, with a Suzhou subsidiary established in 2021 by Dr. Yong Jun, a Peking University Ph.D. with postdoctoral experience at Harvard University who has specialized in single-cell sequencing and stem cell regenerative biology. The core team includes talent from prominent institutions such as Tsinghua University and Harvard University. Dr. Jun's research, published in journals like Science and Cell, underpins the company's scientific foundation.

Geek Gene has developed three core technology platforms: a single-cell multi-omics data collection platform, a low-cost high-throughput omics technology platform, and a cell fate reprogramming technology platform. These platforms led to the creation of its proprietary "Cell Fate Navigation System," which innovates the preparation of T-cells and other immune cells by enhancing their anti-tumor potential. The company's initial product pipeline includes tumor-reactive T-cells (GK01) that have demonstrated promising efficacy in preclinical animal models. The business model involves providing single-cell sequencing services to research institutions and corporations, and developing novel cell therapies. In February 2023, the company secured a Pre-A round of financing to advance its technology platforms and product pipelines through clinical research. Its project for developing novel T-cell drugs was recognized as a "National Disruptive Technology" by China's Ministry of Science and Technology in 2023.

Keywords: cell therapy, T-cell therapy, solid tumors, oncology, single-cell sequencing, high-throughput omics, cell reprogramming, regenerative biology, drug development, immunotherapy, genomics, bioinformatics, preclinical studies, life sciences, biotechnology